Skip to content
Riskpilot
← Back to search
Sign in
Get full access
RegulaPharm AB
AB
Active
Org 5569604506
Activities of holding companies
· NACE 6421
Est. 2014
0 employees
Watchlist
Share
Sweden
/
Companies
/
Activities of holding companies
/
RegulaPharm AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
-1M
2021
-1M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
—
—
—
Staff expenses
—
—
—
—
—
EBITDA
−597
−554
−445
−219
−256
Depreciation & amort.
−0
—
—
—
—
EBIT
−597
−554
−445
−219
−256
Net financials
1 187
3 694
2 236
3 085
1 432
Profit before tax
590
3 140
1 791
2 866
1 176
Tax
−0
—
—
—
—
Net profit
590
3 140
1 791
2 866
1 176
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
88 153
80 352
62 101
64 939
66 119
Equity
87 964
80 104
61 895
64 761
65 937
Long-term debt
0
—
—
—
—
Short-term debt
189
247
206
178
183
Total debt
189
247
206
178
183
Financial ratios
5-year trend
EBITDA margin
-25591200.0%
This company
15.8%
Market median
-161969720% vs market
2021
2025
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
2021
2025
Return on equity
1.8%
This company
18.4%
Market median
-90% vs market
2021
2025
Net profit margin
117592800.0%
This company
8.1%
Market median
+1451762863% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on RegulaPharm AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network